Search

Search Constraints

You searched for: Author/Creator Limongelli, G

Search Results

2. C64 UNMASKING THE PREVALENCE OF AMYLOID CARDIOMYOPATHY IN THE REAL WORLD: RESULTS FROM PHASE 2 OF AC–TIVE STUDY, AN ITALIAN NATIONWIDE SURVEY. (18th May 2022)

3. Cardiovascular death risk in mid-range ejection fraction heart failure: insights from cardiopulmonary exercise test. (14th October 2021)

4. Clinical phenotype and long-term outcome of patients with Anderson-Fabry disease followed at a multidisciplinary cardiomyopathy centre. (3rd October 2022)

5. Diagnostic and prognostic implications of myocardial work in cardiac amyloidosis and in genetic and non-genetic cardiomyopathies with hypertrophic phenotype. (4th February 2022)

6. Diagnostic and prognostic implications of right ventricular-arterial coupling in cardiac amyloidosis and in genetic and non-genetic cardiomyopathies with hypertrophic phenotype. (4th February 2022)

7. Effect of migalastat on cardiac involvement in Fabry disease: preliminary results from MAIORA study. (14th October 2021)

8. HCM-AF South Italy score for prediction of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy: data from a derivation and validation italian cohorts. (3rd October 2022)